Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 0.362% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) COc1ccc(/C=C2\SC(=O)N(CC(=O)NCCCn3ccnc3)C2=O)cc1
(b) CCC(=O)Nc1ccc(NC(=O)c2ccc3c(c2)OCO3)cc1
Answer: b. CCC(=O)Nc1ccc(NC(=O)c2ccc3c(c2)OCO3)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccc(NC(=O)c2ccc3c(c2)OCO3)cc1
CCC(=O)Nc1ccc(NC(=O)c2ccc3c(c2)OCO3)cc1
N-[4-(propanoylamino)phenyl]-1,3-benzodioxole-5-carboxamide